A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

NCT01676259 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer

Interventions

DRUG: siG12D-LODER
DRUG: Gemcitabine+nab-Paclitaxel
DRUG: Folfirinox

Sponsor

Silenseed Ltd